Asia Pacific Hemodialysis Catheters Market

Asia Pacific Hemodialysis Catheters Market Size & Growth (2023 to 2028):

The Size of the Asia Pacific Hemodialysis Catheters Market was valued at USD 154.82 million in 2023 and is expected to reach USD 208.04 million by 2028, registering at a CAGR of 6.09% from 2023 to 2028.

Factors such as the rising frequency of end-stage renal disease (ESRD) and the increasing number of patients suffering from chronic kidney disease propel the hemodialysis catheters market forward. Furthermore, the market is predicted to rise due to a lack of kidney donors for transplantation and technological advancements in dialysis equipment.

In addition, the insertion of intravascular devices, particularly catheters, is the leading source of healthcare-associated bloodstream infections. Other critical factors expected to fuel the growth of the APAC Hemodialysis Catheters Market include an increase in the frequency of chronic disease and related risk determinants such as diabetes, cardiovascular disease, and hypertension.

In addition, an increase in the popularity of antimicrobial-coated hemodialysis catheters, a boost in R&D spending for developing novel hemodialysis products, and a preference for home hemodialysis (HHD) treatment contribute to the market's expansion. Furthermore, the regional market has grown due to the rise in chronic renal diseases caused by an unhealthy lifestyle and the number of deaths caused by kidney disorders. Other factors supporting the market's growth include significant advances by key companies like Fresenius Medical Care.

Limitations hamper the market's growth in medical reimbursement for dialysis procedures in this country, as well as an increase in the risk of blood infection and thrombosis. As a result, hemodialysis has a two to threefold increased risk of death, a five to tenfold increased chance of severe illness, and increased hospitalization, among other long-term hazards.

Hemodialysis catheters also have several side effects, including low blood pressure (hypotension), muscle cramps, itching, sleeping issues, and anemia. In some circumstances, this causes challenges and significant health problems. Blood infections and thrombosis are key significant hurdles for the hemodialysis catheter business. Infection is the primary cause of death in ESRD patients, and the use of vascular devices in hemodialysis raises the risk of infection significantly.

This research report on the Asia Pacific Hemodialysis Catheters Market has been segmented and sub-segmented into the following categories.

By Product:

• Cuffed tunneled catheters
• Non-cuffed tunneled catheters
• Non-tunneled catheters

By Tip Configuration:

• Step-tip catheters
• Split-tip catheters
• Symmetric catheters

By Material:

• Silicone
• Polyurethane

By End User:

• Hospitals
• Clinics
• Home Dialysis

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the Asia Pacific region dominated the hemodialysis market, which is likely to continue during the forecast period. The China hemodialysis catheter market has effective hemodialysis centers, and attractive reimbursement rules drive the expansion. In addition, the availability of professionals (nephrologists) and well-equipped dialysis clinics for patient treatment in the Asia Pacific drives the market's growth.

India hemodialysis catheters market is expected to reach a high CAGR due to the high percentage of older adults susceptible to renal disorders during the forecast period. On the other hand, Japan hemodialysis catheters market is the largest developed market for global in APAC because of dialysis centers with an extensive network and a high adoption rate. In addition, as compared to other nations such as India and China, Japan has a comparatively high rate of home dialysis adoption.

Furthermore, factors such as the growing preference for peritoneal dialysis and the expanding use of home hemodialysis (HHD) boost the market's growth. In addition, large patient pools with kidney-related disorders, an increase in aged care facilities, private dialysis clinics with improved healthcare infrastructure, and ever-increasing insurance penetration with rising per capita income are all driving the region's expansion.

KEY MARKET PLAYERS

Top Companies dominating the Asia Pacific Hemodialysis Catheters Market Profiled in the Report are Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd, Toray Medical Co., Ltd., Asahi Kasei Medical Co., Ltd, Nipro Medical Corporation, B. Braun Melsungen AG, Baxter International Inc.,